SAN FRANCISCO, Calif. — A newly published market research report from Neurotech Reports, the leading market intelligence firm in the neurotechnology industry, forecasts that the worldwide market for bioelectronic medicine and related technologies will reach $16.6 billion by 2025. “The Market for Bioelectronic Medicine: 2020-2025” takes an in-depth look at the technology, markets, competitors, research, and growth rates in key application areas in the years 2020 through 2025.
“Bioelectronic medicine represents one of the most promising areas of healthcare and medical technology,” said James Cavuoto, editor and publisher of Neurotech Reports. “Our team of editors and market research forecasters has more experience and expertise in this area than any other market intelligence organization.”
The research report forecasts U.S. and worldwide revenue, compound annual growth rates, and competitor market shares for bioelectronic medicine devices in several key indications, including inflammatory disorders, hypertension, gastrointestinal disorders, urological disorders, cardiac disorders, metabolic disorders, and ENT disorders. It features in-depth profiles of established and startup bioelectronic medicine firms and key research institutions developing new bioelectronic and neuromodulation therapies.
A unique feature of this report is that it breaks down U.S. and worldwide revenue between core applications that conform to a classic definition of bioelectronic medicine-neuromodulation that affects an end organ-and applications that conform to an expanded definition that includes neuromodulation for neurological disorders. Also highlighted in the report is detailed information on key private and public funding agencies and venture capital firms that are investing in this space.
Authors of the report include Neurotech Reports editors James Cavuoto, Jennifer French, Jeremy Koff, and Margot Puerta. Puerta is the former editor of the journal Bioelectronic Medicine. A team of prominent industry experts also contributed valuable input to the study including Tony Arnold, principal of the consulting firm Precys and former CEO of SetPoint Medical, and Victor Pikov, CEO of Medipace Inc. and former research platforms director at Galvani Bioelectronics.
The report is available through the Neurotech Reports website: http://www.neurotechreports.com/pages/mbmsumm.html.
About Neurotech Reports:
Neurotech Reports is the leading source of news and analysis specific to the neurotechnology industry. The firm publishes the monthly newsletter Neurotech Business Report, and also produces two annual investment conferences: the Neurotech Leaders Forum, now in its 19th year, and the Bioelectronic Medicine Forum, now in its second year. Neurotech Reports also offers strategic consulting services to commercial firms and research organizations in neuromodulation and bioelectronic medicine. Learn more at: http://www.neurotechreports.com/.
*VIDEO: Neurotech Reports editor James Cavuoto offered an overview of the report at the 2019 Bioelectronic Medicine Forum in New York – https://youtu.be/KHo6P-dYiYE
*IMAGE link for media: Send2Press.com/300dpi/19-0509s2p-nr-chart-300dpi.jpg
*Caption: “The Market for Bioelectronic Medicine: 2020-2025” examines core applications involving neuromodulation that affects an end organ, but also forecasts the market in an expanded definition that includes more traditional forms of neuromodulation.
Related link: http://www.neurotechreports.com/
This news story was published by the Neotrope® News Network – all rights reserved.